← Open Payments lookup

OLIVIA LEBER: Open Payments

NPI 1396486551 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,245 in 82 payments from 14 companies in 2025. Trend: 2023 $960 · 2024 $710 · 2025 $1,245

Food & beverage: $1,245
CompanyPaymentsAmount
Axsome Therapeutics, Inc.14$192
ABBVIE INC.12$163
Janssen Pharmaceuticals, Inc12$156
Vanda Pharmaceuticals Inc.11$154
Otsuka America Pharmaceutical, Inc.12$152
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$100
Takeda Pharmaceuticals U.S.A., Inc.3$66
Tris Pharma Inc3$63
Alkermes, Inc.3$61
E.R. Squibb & Sons, L.L.C.3$56

Products named: REXULTI, VRAYLAR, SPRAVATO, FANAPT, Auvelity, CAPLYTA, Sunosi, TRINTELLIX.

Industry payments across MS — which companies pay providers there.